(Q37583633)

21 August 2017

1 reference

title

Behçet's disease: an algorithmic approach to its treatment (English)

1 reference

21 August 2017

0 references

Erkan Alpsoy

1

1 reference

PubMed ID

19697053

21 August 2017

Ayse Akman

series ordinal

2

1 reference

21 August 2017

21 August 2009

1 reference

Archives of Dermatological Research

21 August 2017

1 reference

21 August 2017

301

1 reference

21 August 2017

10

1 reference

21 August 2017

693-702

1 reference

https://scigraph.springernature.com/pub.10.1007/s00403-009-0990-2

21 August 2017

0 references

cites work

Effect of cyclosporine A on the hearing loss in Behçet's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00403-009-0990-2

Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-009-0990-2

Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-009-0990-2

Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-009-0990-2

A controlled trial of azathioprine in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-009-0990-2

Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-009-0990-2

10.1007/S00403-009-0990-2

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19697053